• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Palliat Med . Electrocardiographic findings over time and their prognostic value in patients with COVID-19

tetano

Editor, Senior Moderator
Ann Palliat Med


. 2021 Dec;10(12):12280-12290.
doi: 10.21037/apm-21-3188.
Electrocardiographic findings over time and their prognostic value in patients with COVID-19


Ye Su[SUP] 1 [/SUP], Lixue Yin[SUP] 1 [/SUP], Jun Lin[SUP] 2 [/SUP], Qionghui Peng[SUP] 3 [/SUP], Rui Shi[SUP] 2 [/SUP], Dana Zhu[SUP] 2 [/SUP], Huanxing Li[SUP] 2 [/SUP]



Affiliations

Abstract

Background: The objective of this study was to carry out a retrospective analysis of the progression of electrocardiographic (ECG) findings over time, based on biomarkers for myocardial injuries in patients with coronavirus disease 2019 (COVID-19). Also, the ECG observations were assessed for possible prognostic use.
Methods: Diagnostic criteria provided by the Coronavirus Pneumonia Diagnosis and Treatment Program of the Chinese National Health Commission were used. We conducted a retrospective analysis of 31 COVID-19 cases diagnosed as positive by high-throughput sequencing of nasopharyngeal nucleic acid test and admitted to Sichuan Province Public Health Clinical Medical Center, Sichuan Province, China. Based on changes in biomarkers, the 31 participants were divided into a non-myocardial injury group (A) and a myocardial injury group (B). Our study observed the dynamic changes and new abnormal changes of the ECG during the hospitalization of patients.
Results: The results summarized in the 4 following points: (I) the time sequence changes for ST and T indicated that the absolute ST-segment depression and T-wave inversion values in group B were larger. (II) The heart rate (HR) and RV5 values in group B were higher, the QTC value for group B was lower. (III) The sensitivity of ST-segment depression for the diagnosis of myocardial injury was 32.60% and the specificity was 90.50%. The sensitivity of T-wave inversion was 41.30% and the specificity was 85.10%. (IV) Lactate dehydrogenase (LDH) is a major factor affecting patient's death.
Conclusions: If abnormal ST-T, increased heart rate, shortened QTC interval, and high ventricular voltage are observed in a COVID-19 patient, it may infer that myocardial damage has occurred. Using ECG as a point of reference for change can compensate for the time limitation of myocardial enzyme index. Regardless of the stage of disease development, ECG can reflect myocardial damage. Particularly in the 8-12 days after hospitalization, almost all myocardial enzymes cannot be applied. The ST-depression and T-wave inversion had diagnostic significance with relatively high sensitivity and specificity for myocardial injury. Assessment of LDH and biomarkers in combination with ECG can more accurately reflect myocardial injury, and facilitate prompt clinical diagnosis and treatment.

Keywords: COVID-19; biomarker; electrocardiogram; myocardial injury.
 
Back
Top Bottom